GLP-1 Effect: FIOS AI Reformulates America’s Food – Food & Beverage Magazine

FIOS AI is reformulating food products in response to the growing market impact of GLP-1 medications, which are increasingly used for weight management and diabetes treatment. The company is adapting its approach to address changing consumer preferences and dietary needs driven by GLP-1 adoption across the United States. This shift reflects the broader food and beverage industry’s response to evolving consumer health trends.

Read Full Article →